Maturation of the Autonomic Nervous System in Prematures

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Analysis, Event History Clinical Trial

Official title:
Maturation of the Autonomic Nervous System in Prematures

Status Completed

Clinical Trial Summary

The purpose of this study is to try to evaluate the maturation of the autonomic nervous system in prematures.

To evaluate the maturation of the autonomic nervous system in prematures by using heart rate variability analyses. ;

Observational Model: Case-Only, Time Perspective: Prospective

See also
Status	Clinical Trial	Phase
Completed	`NCT01921023` - Comparison of Performance of a Conventional Blood Gas Analyser With the Proxima System	N/A
Completed	`NCT03242525` - Examination of the Time Advantage Between POCT and Conventional Central Laboratory Analysis
Completed	`NCT02919657` - Absorption Comparison on Equivalency Value of Genepro Gen2	Phase 4
Completed	`NCT02838654` - Cervical Epidural Waveform Analysis Using Pressure Monitoring Kit	N/A
Completed	`NCT03245294` - Factors Contributing to the Pressure Wave Form Changes	N/A